FIBROBIOLOGICS INC (FBLG)

US31573L1052 - Common Stock

1.985  -0.01 (-0.75%)

After market: 1.99 +0 (+0.25%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
Revenue
0.000.000.000.00
Operating Expenses
12.51M8.89M4.47M1.58M
Research and Development
3.92M2.37M1.15M521.00K
Selling, General, and Administrative Expenses
8.59M6.52M3.32M1.06M
Operating Income
-12.51M-8.89M-4.47M-1.58M
Interest Income/Expense
173.00K-147.00K-654.00K-4.00K
Other Income/Expense
-5.45M-7.45MN/AN/A
Income Before Taxes
-17.78M-16.48M-5.12M-1.58M
Net Income
-17.78M-19.06M-5.12M-1.58M
EBITDA
-12.37M-8.84MN/AN/A
 
Per Share Data
EPS Diluted Total Ops
-0.89-0.68-0.16-0.05
 
Statistics

All data in USD

Charts